Carbone, Carmine
Carbone, Carmine
DIPARTIMENTO DI MEDICINA
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.006 secondi).
Anti- VEGF treatment resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype
2011-01-01 Carbone, C.; Moccia, T.; Zhu, C.; Paradiso, G.; Budillon, A.; Chiao, P. J.; Abbruzzese, J. L.; Melisi, Davide
Pro-inflammatory factors secreted by pancreatic cancers with evasive resistance to anti-VEGF treatment contribute to malignant progression by inducing EMT
2011-01-01 Carbone, C.; Moccia, T.; Zhu, C.; Paradiso, G.; Simbolo, Michele; Budillon, A.; Chiao, P. J.; Abbruzzese, J. L.; Melisi, Davide
TGF-beta-activated Kinase 1 (TAK1) is a therapeutic target modulating pancreatic cancer chemoresistance
2010-01-01 Melisi, Davide; Xia, Q.; Moccia, T.; Paradiso, G.; Carbone, C.; Ling, J.; Abbruzzese, J. L.; Budillon, A.; Chiao, P. J.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Anti- VEGF treatment resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype | 1-gen-2011 | Carbone, C.; Moccia, T.; Zhu, C.; Paradiso, G.; Budillon, A.; Chiao, P. J.; Abbruzzese, J. L.; Melisi, Davide | |
Pro-inflammatory factors secreted by pancreatic cancers with evasive resistance to anti-VEGF treatment contribute to malignant progression by inducing EMT | 1-gen-2011 | Carbone, C.; Moccia, T.; Zhu, C.; Paradiso, G.; Simbolo, Michele; Budillon, A.; Chiao, P. J.; Abbruzzese, J. L.; Melisi, Davide | |
TGF-beta-activated Kinase 1 (TAK1) is a therapeutic target modulating pancreatic cancer chemoresistance | 1-gen-2010 | Melisi, Davide; Xia, Q.; Moccia, T.; Paradiso, G.; Carbone, C.; Ling, J.; Abbruzzese, J. L.; Budillon, A.; Chiao, P. J. |